What does Gilead Sciences, Inc. do?

Jun 22 2025 05:57 PM IST
share
Share Via
Gilead Sciences, Inc. is a large-cap biopharmaceutical company focused on discovering, developing, and commercializing medicines, with a net sales of $6.646 billion and a market cap of approximately $134.34 billion as of March 2025. Key financial metrics include a P/E ratio of 15.00 and a dividend yield of 2.89%.
Overview:
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes medicines in the Pharmaceuticals & Biotechnology industry, classified as a large-cap company.

Financial Snapshot:
Net Sales: 6,646 Million (Quarterly Results - Mar 2025)
Net Profit: 1,315 Million (Quarterly Results - Mar 2025)
Market cap: USD 134,344.34 Million (Large Cap)

Key Metrics:
P/E: 15.00
Dividend Yield: 2.89%
Debt Equity: 0.83
Return on Equity: 49.06%
Price to Book: 7.01

Contact Details:
Address: 333 LAKESIDE DR, FOSTER CITY CA: 94404
Tel: 1 650 5743000
Fax: 1 650 5789264
Website: https://www.gilead.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News